A phase 2 study of ifinatamab deruxtecan (I-DXd; DS-7300) in patients with previously treated ES-SCLC Meeting Abstract
| Authors: | Rudin, C.; Johnson, M.; Girard, N.; Hann, C. L.; Ahn, M. J.; Nishio, M.; Godard, J.; Arca, M.; Qian, M.; Singh, J.; Paz-Ares, L. |
| Abstract Title: | A phase 2 study of ifinatamab deruxtecan (I-DXd; DS-7300) in patients with previously treated ES-SCLC |
| Meeting Title: | 2023 World Conference on Lung Cancer (IASLC-WCLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 11 Suppl. |
| Meeting Dates: | 2023 Sep 9-11 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-11-01 |
| Start Page: | S377 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2023.09.667 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: P2.16-06 -- Source: Cinahl |
